(+)-schisandrin B multiple interactions EXP 6480464 schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of NFIB mRNA] CTD PMID:31150632 1,2-dichloroethane decreases expression ISO RGD:62307 6480464 ethylene dichloride results in decreased expression of NFIB mRNA CTD PMID:28960355 1,2-dimethylhydrazine affects expression ISO RGD:62307 6480464 1, 2-Dimethylhydrazine affects the expression of NFIB mRNA CTD PMID:22206623 17alpha-ethynylestradiol decreases expression EXP 6480464 Ethinyl Estradiol results in decreased expression of NFIB mRNA CTD PMID:12655037 17beta-estradiol affects expression ISO RGD:733820 6480464 Estradiol affects the expression of NFIB mRNA CTD PMID:14699072 17beta-estradiol decreases expression ISO RGD:733820 6480464 Estradiol results in decreased expression of NFIB mRNA CTD PMID:19167446 17beta-estradiol multiple interactions ISO RGD:733820 6480464 [Estradiol co-treated with Progesterone] results in increased expression of NFIB mRNA, [Progesterone co-treated with Estradiol] results in increased expression of NFIB mRNA CTD PMID:17404688 , PMID:20660070 17beta-hydroxy-5alpha-androstan-3-one increases expression ISO RGD:733820 6480464 Dihydrotestosterone results in increased expression of NFIB mRNA CTD PMID:29581250 2,2',4,4',5,5'-hexachlorobiphenyl multiple interactions ISO RGD:62307 6480464 [2 more ... CTD PMID:25510870 2,2',4,4'-Tetrabromodiphenyl ether decreases expression EXP 6480464 2 more ... CTD PMID:21394737 2,2',5,5'-tetrachlorobiphenyl increases expression EXP 6480464 2 more ... CTD PMID:23829299 2,2',5,5'-tetrachlorobiphenyl multiple interactions ISO RGD:62307 6480464 [2 more ... CTD PMID:25510870 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:62307 6480464 Tetrachlorodibenzodioxin affects the expression of NFIB mRNA CTD PMID:21570461 , PMID:24058054 2,3,7,8-tetrachlorodibenzodioxine affects expression EXP 6480464 Tetrachlorodibenzodioxin affects the expression of NFIB mRNA CTD PMID:32109520 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of NFIB mRNA CTD PMID:20959002 more ... 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:62307 6480464 Tetrachlorodibenzodioxin results in increased expression of NFIB mRNA CTD PMID:16922920 2,3,7,8-Tetrachlorodibenzofuran decreases expression EXP 6480464 2 more ... CTD PMID:32109520 2,4-dinitrotoluene affects expression EXP 6480464 2, 4-dinitrotoluene affects the expression of NFIB mRNA CTD PMID:21346803 2-hydroxypropanoic acid increases expression ISO RGD:733820 6480464 Lactic Acid results in increased expression of NFIB mRNA CTD PMID:30851411 3H-1,2-dithiole-3-thione decreases expression EXP 6480464 1, 2-dithiol-3-thione results in decreased expression of NFIB mRNA CTD PMID:19162173 4,4'-diaminodiphenylmethane decreases expression EXP 6480464 4, 4'-diaminodiphenylmethane results in decreased expression of NFIB mRNA CTD PMID:30723492 4-amino-2,6-dinitrotoluene affects expression EXP 6480464 4-amino-2, 6-dinitrotoluene affects the expression of NFIB mRNA CTD PMID:21346803 4-hydroxyphenyl retinamide decreases expression ISO RGD:62307 6480464 Fenretinide results in decreased expression of NFIB mRNA CTD PMID:28973697 5-fluorouracil decreases expression ISO RGD:733820 6480464 Fluorouracil results in decreased expression of NFIB mRNA CTD PMID:16557594 acetamide decreases expression EXP 6480464 acetamide results in decreased expression of NFIB mRNA CTD PMID:31881176 all-trans-retinoic acid increases expression ISO RGD:733820 6480464 Tretinoin results in increased expression of NFIB mRNA CTD PMID:21934132 all-trans-retinoic acid multiple interactions ISO RGD:62307 6480464 [bisphenol F co-treated with Tretinoin] results in decreased expression of NFIB mRNA CTD PMID:30951980 ammonium chloride affects expression EXP 6480464 Ammonium Chloride affects the expression of NFIB mRNA CTD PMID:16483693 antirheumatic drug increases expression ISO RGD:733820 6480464 Antirheumatic Agents results in increased expression of NFIB mRNA CTD PMID:24449571 aristolochic acid A decreases expression ISO RGD:733820 6480464 aristolochic acid I results in decreased expression of NFIB mRNA CTD PMID:33212167 Aroclor 1254 decreases expression EXP 6480464 Chlorodiphenyl (54% Chlorine) results in decreased expression of NFIB mRNA CTD PMID:18178546 Aroclor 1254 decreases expression ISO RGD:62307 6480464 Chlorodiphenyl (54% Chlorine) results in decreased expression of NFIB mRNA CTD PMID:23650126 arsane multiple interactions ISO RGD:733820 6480464 [Arsenic co-treated with Iron] results in decreased expression of NFIB mRNA CTD PMID:31739468 arsane decreases expression ISO RGD:733820 6480464 Arsenic results in decreased expression of NFIB mRNA CTD PMID:31739468 arsenic atom decreases expression ISO RGD:733820 6480464 Arsenic results in decreased expression of NFIB mRNA CTD PMID:31739468 arsenic atom multiple interactions ISO RGD:733820 6480464 [Arsenic co-treated with Iron] results in decreased expression of NFIB mRNA CTD PMID:31739468 benzene increases expression ISO RGD:733820 6480464 Benzene results in increased expression of NFIB mRNA CTD PMID:20359517 benzo[a]pyrene decreases expression ISO RGD:62307 6480464 Benzo(a)pyrene results in decreased expression of NFIB mRNA CTD PMID:19770486 , PMID:21569818 benzo[a]pyrene increases expression ISO RGD:733820 6480464 Benzo(a)pyrene results in increased expression of NFIB mRNA CTD PMID:31255691 benzo[a]pyrene diol epoxide I decreases expression ISO RGD:733820 6480464 7 more ... CTD PMID:19150397 more ... Benzo[ghi]perylene increases expression ISO RGD:62307 6480464 1, 12-benzoperylene results in increased expression of NFIB mRNA CTD PMID:26377693 bis(2-chloroethyl) sulfide affects expression EXP 6480464 Mustard Gas affects the expression of NFIB mRNA CTD PMID:15651846 bisphenol A increases expression ISO RGD:62307 6480464 bisphenol A results in increased expression of NFIB mRNA CTD PMID:26063408 bisphenol A multiple interactions ISO RGD:733820 6480464 [bisphenol A co-treated with Fulvestrant] results in decreased methylation of NFIB gene, [Phenolsulfonphthalein deficiency co-treated with bisphenol A] results in increased expression of NFIB protein CTD PMID:31601247 , PMID:31629898 bisphenol A decreases expression ISO RGD:733820 6480464 bisphenol A results in decreased expression of NFIB mRNA CTD PMID:25912373 bisphenol A affects expression EXP 6480464 bisphenol A affects the expression of NFIB mRNA CTD PMID:25181051 , PMID:30816183 bisphenol F multiple interactions ISO RGD:62307 6480464 [bisphenol F co-treated with Tretinoin] results in decreased expression of NFIB mRNA CTD PMID:30951980 Brodifacoum decreases expression EXP 6480464 bromfenacoum results in decreased expression of NFIB protein CTD PMID:28903499 butanal decreases expression ISO RGD:733820 6480464 butyraldehyde results in decreased expression of NFIB mRNA CTD PMID:26079696 cadmium atom multiple interactions ISO RGD:733820 6480464 [Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of NFIB mRNA CTD PMID:35301059 cadmium dichloride decreases expression ISO RGD:733820 6480464 Cadmium Chloride results in decreased expression of NFIB mRNA CTD PMID:18560533 cadmium dichloride multiple interactions ISO RGD:733820 6480464 [Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of NFIB mRNA CTD PMID:35301059 carbon nanotube decreases expression ISO RGD:62307 6480464 Nanotubes more ... CTD PMID:25554681 carmustine affects response to substance ISO RGD:733820 6480464 NFIB mRNA affects the susceptibility to Carmustine CTD PMID:16365179 CGP 52608 multiple interactions ISO RGD:733820 6480464 CGP 52608 promotes the reaction [RORA protein binds to NFIB gene] CTD PMID:28238834 chlordecone increases expression ISO RGD:62307 6480464 Chlordecone results in increased expression of NFIB mRNA CTD PMID:33711761 chlorpyrifos decreases expression EXP 6480464 Chlorpyrifos results in decreased expression of NFIB mRNA CTD PMID:18668222 cisplatin decreases expression ISO RGD:733820 6480464 Cisplatin results in decreased expression of NFIB mRNA CTD PMID:19561079 , PMID:27392435 cisplatin multiple interactions ISO RGD:733820 6480464 [Cisplatin co-treated with jinfukang] results in decreased expression of NFIB mRNA CTD PMID:27392435 cobalt dichloride decreases expression ISO RGD:733820 6480464 cobaltous chloride results in decreased expression of NFIB mRNA CTD PMID:19320972 copper atom increases expression EXP 6480464 Copper results in increased expression of NFIB mRNA CTD PMID:30556269 copper(0) increases expression EXP 6480464 Copper results in increased expression of NFIB mRNA CTD PMID:30556269 copper(II) sulfate increases expression ISO RGD:733820 6480464 Copper Sulfate results in increased expression of NFIB mRNA CTD PMID:19549813 coumarin decreases phosphorylation ISO RGD:733820 6480464 coumarin results in decreased phosphorylation of NFIB protein CTD PMID:35688186 crocidolite asbestos decreases expression ISO RGD:62307 6480464 Asbestos, Crocidolite results in decreased expression of NFIB mRNA CTD PMID:29279043 Cuprizon decreases expression EXP 6480464 Cuprizone results in decreased expression of NFIB mRNA CTD PMID:26577399 cyclosporin A decreases expression ISO RGD:733820 6480464 Cyclosporine results in decreased expression of NFIB mRNA CTD PMID:20106945 , PMID:27989131 cyclosporin A decreases expression ISO RGD:62307 6480464 Cyclosporine results in decreased expression of NFIB mRNA CTD PMID:19770486 cyproconazole decreases expression ISO RGD:62307 6480464 cyproconazole results in decreased expression of NFIB mRNA CTD PMID:22334560 cytarabine increases expression ISO RGD:733820 6480464 Cytarabine results in increased expression of NFIB mRNA CTD PMID:21198554 dibenzo[a,l]pyrene decreases expression ISO RGD:733820 6480464 dibenzo(a, l)pyrene results in decreased expression of NFIB mRNA CTD PMID:31255691 dichloromethane increases expression ISO RGD:733820 6480464 Methylene Chloride results in increased expression of NFIB mRNA CTD PMID:20359517 diuron decreases expression EXP 6480464 Diuron results in decreased expression of NFIB mRNA CTD PMID:21551480 , PMID:25152437 dorsomorphin multiple interactions ISO RGD:733820 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 doxorubicin decreases expression ISO RGD:62307 6480464 Doxorubicin results in decreased expression of NFIB mRNA CTD PMID:17888722 doxorubicin decreases expression ISO RGD:733820 6480464 Doxorubicin results in decreased expression of NFIB mRNA CTD PMID:29803840 endosulfan decreases expression EXP 6480464 Endosulfan results in decreased expression of NFIB mRNA CTD PMID:29391264 entinostat increases expression ISO RGD:733820 6480464 entinostat results in increased expression of NFIB mRNA CTD PMID:26272509 entinostat multiple interactions ISO RGD:733820 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of NFIB mRNA CTD PMID:27188386 epoxiconazole decreases expression ISO RGD:62307 6480464 epoxiconazole results in decreased expression of NFIB mRNA CTD PMID:22334560 ethanol multiple interactions ISO RGD:62307 6480464 Ethanol affects the expression of and affects the splicing of NFIB mRNA CTD PMID:30319688 ethyl methanesulfonate decreases expression ISO RGD:733820 6480464 Ethyl Methanesulfonate results in decreased expression of NFIB mRNA CTD PMID:23649840 ethylbenzene increases expression ISO RGD:733820 6480464 ethylbenzene results in increased expression of NFIB mRNA CTD PMID:20359517 fenthion increases expression ISO RGD:62307 6480464 Fenthion results in increased expression of NFIB mRNA CTD PMID:34813904 flutamide decreases expression EXP 6480464 Flutamide results in decreased expression of NFIB mRNA CTD PMID:24136188 formaldehyde decreases expression ISO RGD:733820 6480464 Formaldehyde results in decreased expression of NFIB mRNA CTD PMID:23649840 fulvestrant multiple interactions ISO RGD:733820 6480464 [bisphenol A co-treated with Fulvestrant] results in decreased methylation of NFIB gene CTD PMID:31601247 gamma-hexachlorocyclohexane decreases expression EXP 6480464 Hexachlorocyclohexane results in decreased expression of NFIB mRNA CTD PMID:17785943 genistein increases methylation EXP 6480464 Genistein results in increased methylation of NFIB gene CTD PMID:28505145 gentamycin decreases expression EXP 6480464 Gentamicins results in decreased expression of NFIB mRNA CTD PMID:33387578 glafenine decreases expression EXP 6480464 Glafenine results in decreased expression of NFIB mRNA CTD PMID:24136188 iron atom multiple interactions ISO RGD:733820 6480464 [Arsenic co-treated with Iron] results in decreased expression of NFIB mRNA CTD PMID:31739468 iron(0) multiple interactions ISO RGD:733820 6480464 [Arsenic co-treated with Iron] results in decreased expression of NFIB mRNA CTD PMID:31739468 L-ascorbic acid increases expression ISO RGD:62307 6480464 Ascorbic Acid results in increased expression of NFIB mRNA CTD PMID:15305145 leflunomide increases expression ISO RGD:733820 6480464 leflunomide results in increased expression of NFIB mRNA CTD PMID:28988120 maneb multiple interactions ISO RGD:62307 6480464 [Paraquat co-treated with Maneb] affects the expression of NFIB mRNA CTD PMID:22563483 manganese atom increases expression ISO RGD:733820 6480464 Manganese results in increased expression of NFIB mRNA CTD PMID:17175027 manganese(0) increases expression ISO RGD:733820 6480464 Manganese results in increased expression of NFIB mRNA CTD PMID:17175027 manganese(II) chloride increases expression ISO RGD:733820 6480464 manganese chloride results in increased expression of NFIB mRNA CTD PMID:17175027 mercury dibromide increases expression ISO RGD:733820 6480464 mercuric bromide results in increased expression of NFIB mRNA CTD PMID:26272509 mercury dibromide multiple interactions ISO RGD:733820 6480464 [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of NFIB mRNA CTD PMID:27188386 methapyrilene decreases expression EXP 6480464 Methapyrilene results in decreased expression of NFIB mRNA CTD PMID:16393664 , PMID:30467583 methidathion affects expression ISO RGD:62307 6480464 methidathion affects the expression of NFIB mRNA CTD PMID:34813904 N-nitrosodiethylamine decreases expression EXP 6480464 Diethylnitrosamine results in decreased expression of NFIB mRNA CTD PMID:19638242 nefazodone decreases expression EXP 6480464 nefazodone results in decreased expression of NFIB mRNA CTD PMID:24136188 nickel atom decreases expression ISO RGD:733820 6480464 Nickel results in decreased expression of NFIB mRNA CTD PMID:25583101 nickel sulfate decreases expression ISO RGD:733820 6480464 nickel sulfate results in decreased expression of NFIB mRNA CTD PMID:22714537 nimesulide decreases expression EXP 6480464 nimesulide results in decreased expression of NFIB mRNA CTD PMID:24136188 o-xylene increases expression ISO RGD:733820 6480464 2-xylene results in increased expression of NFIB mRNA CTD PMID:20359517 oxaliplatin decreases response to substance ISO RGD:733820 6480464 NFIB protein results in decreased susceptibility to oxaliplatin CTD PMID:21087353 oxaliplatin multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in increased expression of NFIB mRNA CTD PMID:25729387 panobinostat multiple interactions ISO RGD:733820 6480464 [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of NFIB mRNA CTD PMID:27188386 panobinostat increases expression ISO RGD:733820 6480464 panobinostat results in increased expression of NFIB mRNA CTD PMID:26272509 paracetamol affects expression ISO RGD:62307 6480464 Acetaminophen affects the expression of NFIB mRNA CTD PMID:17562736 paracetamol decreases expression EXP 6480464 Acetaminophen results in decreased expression of NFIB mRNA CTD PMID:33387578 paracetamol decreases expression ISO RGD:733820 6480464 Acetaminophen results in decreased expression of NFIB mRNA CTD PMID:21420995 , PMID:26690555 paraquat increases expression ISO RGD:62307 6480464 Paraquat results in increased expression of NFIB mRNA CTD PMID:22563483 paraquat multiple interactions ISO RGD:62307 6480464 [Paraquat co-treated with Maneb] affects the expression of NFIB mRNA CTD PMID:22563483 PCB138 multiple interactions ISO RGD:62307 6480464 [2 more ... CTD PMID:25510870 PCB138 decreases expression EXP 6480464 2 more ... CTD PMID:23829299 perfluorooctane-1-sulfonic acid affects expression ISO RGD:62307 6480464 perfluorooctane sulfonic acid affects the expression of NFIB mRNA CTD PMID:19429403 perfluorooctanoic acid affects expression ISO RGD:62307 6480464 perfluorooctanoic acid affects the expression of NFIB mRNA CTD PMID:19429403 phenobarbital decreases expression EXP 6480464 Phenobarbital results in decreased expression of NFIB mRNA CTD PMID:19162173 phenobarbital decreases expression ISO RGD:62307 6480464 Phenobarbital results in decreased expression of NFIB mRNA CTD PMID:23091169 phenol red multiple interactions ISO RGD:733820 6480464 [Phenolsulfonphthalein deficiency co-treated with bisphenol A] results in increased expression of NFIB protein CTD PMID:31629898 phenylmercury acetate increases expression ISO RGD:733820 6480464 Phenylmercuric Acetate results in increased expression of NFIB mRNA CTD PMID:26272509 phenylmercury acetate multiple interactions ISO RGD:733820 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of NFIB mRNA CTD PMID:27188386 phorbol 13-acetate 12-myristate multiple interactions ISO RGD:733820 6480464 [Zinc co-treated with Tetradecanoylphorbol Acetate] affects the expression of NFIB mRNA CTD PMID:16979875 pirinixic acid decreases expression ISO RGD:62307 6480464 pirinixic acid results in decreased expression of NFIB mRNA CTD PMID:16221962 , PMID:18445702 potassium chromate decreases expression ISO RGD:733820 6480464 potassium chromate(VI) results in decreased expression of NFIB mRNA CTD PMID:22714537 progesterone multiple interactions ISO RGD:733820 6480464 [Estradiol co-treated with Progesterone] results in increased expression of NFIB mRNA, [Progesterone co-treated with Estradiol] results in increased expression of NFIB mRNA CTD PMID:17404688 , PMID:20660070 progesterone increases expression ISO RGD:733820 6480464 Progesterone results in increased expression of NFIB mRNA CTD PMID:17404688 propiconazole decreases expression ISO RGD:62307 6480464 propiconazole results in decreased expression of NFIB mRNA CTD PMID:21278054 more ... Ptaquiloside decreases expression ISO RGD:62307 6480464 ptaquiloside results in decreased expression of NFIB mRNA CTD PMID:23274088 pyridaben increases expression ISO RGD:62307 6480464 pyridaben results in increased expression of NFIB mRNA CTD PMID:22563483 rac-lactic acid increases expression ISO RGD:733820 6480464 Lactic Acid results in increased expression of NFIB mRNA CTD PMID:30851411 SB 431542 multiple interactions ISO RGD:733820 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 sodium arsenate decreases expression ISO RGD:62307 6480464 sodium arsenate results in decreased expression of NFIB mRNA CTD PMID:21795629 sodium arsenate increases expression ISO RGD:62307 6480464 sodium arsenate results in increased expression of NFIB mRNA CTD PMID:21795629 sodium arsenite decreases expression ISO RGD:733820 6480464 sodium arsenite results in decreased expression of NFIB mRNA CTD PMID:34032870 sodium arsenite decreases expression ISO RGD:62307 6480464 sodium arsenite results in decreased expression of NFIB mRNA CTD PMID:36209798 sulindac multiple interactions EXP 6480464 [Sulindac co-treated with lipopolysaccharide, E coli O55-B5] affects the expression of NFIB mRNA CTD PMID:20371263 sunitinib decreases expression ISO RGD:733820 6480464 Sunitinib results in decreased expression of NFIB mRNA CTD PMID:31533062 temozolomide affects response to substance ISO RGD:733820 6480464 NFIB mRNA affects the susceptibility to temozolomide CTD PMID:16365179 testosterone multiple interactions ISO RGD:62307 6480464 1 more ... CTD PMID:33848595 testosterone increases expression ISO RGD:62307 6480464 Testosterone deficiency results in increased expression of NFIB mRNA CTD PMID:33848595 tetrachloromethane affects expression ISO RGD:62307 6480464 Carbon Tetrachloride affects the expression of NFIB mRNA CTD PMID:17484886 tetrachloromethane decreases expression ISO RGD:62307 6480464 Carbon Tetrachloride results in decreased expression of NFIB mRNA CTD PMID:31919559 tetrachloromethane multiple interactions EXP 6480464 schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of NFIB mRNA] CTD PMID:31150632 tetrachloromethane decreases expression EXP 6480464 Carbon Tetrachloride results in decreased expression of NFIB mRNA CTD PMID:31150632 thioacetamide decreases expression EXP 6480464 Thioacetamide results in decreased expression of NFIB mRNA CTD PMID:34492290 titanium dioxide decreases expression ISO RGD:62307 6480464 titanium dioxide results in decreased expression of NFIB mRNA CTD PMID:23557971 titanium dioxide decreases methylation ISO RGD:733820 6480464 titanium dioxide results in decreased methylation of NFIB gene CTD PMID:34973136 toluene increases expression ISO RGD:733820 6480464 Toluene results in increased expression of NFIB mRNA CTD PMID:20359517 topotecan multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in increased expression of NFIB mRNA CTD PMID:25729387 trichloroethene increases expression ISO RGD:733820 6480464 Trichloroethylene results in increased expression of NFIB mRNA CTD PMID:20359517 trichloroethene increases expression ISO RGD:62307 6480464 Trichloroethylene results in increased expression of NFIB mRNA CTD PMID:15363585 , PMID:19448997 trichloroethene increases expression EXP 6480464 Trichloroethylene results in increased expression of NFIB mRNA CTD PMID:19448997 trimellitic anhydride decreases expression ISO RGD:62307 6480464 trimellitic anhydride results in decreased expression of NFIB mRNA CTD PMID:19042947 triptonide increases expression ISO RGD:62307 6480464 triptonide results in increased expression of NFIB mRNA CTD PMID:33045310 tris(2-butoxyethyl) phosphate affects expression ISO RGD:733820 6480464 tris(2-butoxyethyl) phosphate affects the expression of NFIB mRNA CTD PMID:29024780 troglitazone decreases expression ISO RGD:62307 6480464 troglitazone results in decreased expression of NFIB mRNA CTD PMID:28973697 valproic acid decreases expression ISO RGD:733820 6480464 Valproic Acid results in decreased expression of NFIB mRNA CTD PMID:23179753 more ... valproic acid affects splicing EXP 6480464 Valproic Acid affects the splicing of NFIB mRNA CTD PMID:29427782 valproic acid increases expression ISO RGD:733820 6480464 Valproic Acid results in increased expression of NFIB mRNA CTD PMID:23179753 , PMID:27188386 vinclozolin affects expression EXP 6480464 vinclozolin affects the expression of NFIB mRNA CTD PMID:19015723 zinc atom multiple interactions ISO RGD:733820 6480464 [Zinc co-treated with Tetradecanoylphorbol Acetate] affects the expression of NFIB mRNA CTD PMID:16979875 zinc(0) multiple interactions ISO RGD:733820 6480464 [Zinc co-treated with Tetradecanoylphorbol Acetate] affects the expression of NFIB mRNA CTD PMID:16979875